Pharmaceuticals (468) | Mergers & Acquisitions (468)

Browse by Subcategory

Browse by Company

4Front Ventures Corp. (5 contracts)
60 DEGREES PHARMACEUTICALS, INC. (3)
Acasti Pharma Inc. (1)
ACELRX PHARMACEUTICALS INC (3)
Acer Therapeutics Inc. (1)
ACHILLION PHARMACEUTICALS INC (1)
Adamis Pharmaceuticals Corp (7)
AERIE PHARMACEUTICALS INC (1)
Aerpio Pharmaceuticals, Inc. (2)
Akers Biosciences, Inc. (2)
Akorn (3)
ALDER BIOPHARMACEUTICALS INC (1)
Alexza Pharmaceuticals Inc. (1)
Allergan, plc (8)
Amag Pharmaceuticals (1)
Amneal Pharmaceuticals, Inc. (6)
Ampio Pharmaceuticals, Inc. (4)
AMYLIN PHARMACEUTICALS INC (1)
Anacor Pharmaceuticals, Inc. (1)
ANADYS PHARMACEUTICALS INC (1)
Angion Biomedica Corp. (1)
ANGIOTECH PHARMACEUTICALS INC (1)
ANI Pharma Inc (7)
APP Pharmaceuticals, Inc. (3)
APRICUS BIOSCIENCES, INC. (5)
ARIAD PHARMACEUTICALS INC (3)
Artemis Therapeutics, Inc. (1)
Assertio Holdings, Inc. (1)
Assertio Therapeutics, Inc (3)
Astex Pharmaceuticals, Inc (1)
Auspex Pharmaceuticals, Inc. (1)
AUXILIUM PHARMACEUTICALS INC (2)
AVADEL PHARMACEUTICALS PLC (1)
AVALON PHARMACEUTICALS INC (3)
AVANIR PHARMACEUTICALS, INC. (1)
AVENUE THERAPEUTICS, INC. (1)
AYTU BIOSCIENCE, INC (5)
BARR PHARMACEUTICALS INC (2)
Bausch Health Companies Inc. (6)
BENTLEY PHARMACEUTICALS INC (2)
Big Rock Partners Acquisition Corp. (3)
BIODELIVERY SCIENCES INTERNATIONAL INC (2)
BioNumerik Pharmaceuticals, Inc. (3)
BioPharmX Corp (2)
Blue Water Acquisition Corp. (1)
BODY & MIND INC. (1)
Boston Therapeutics, Inc. (6)
Bright Green Corp (3)
Bristol-Myers Squibb (2)
CADENCE PHARMACEUTICALS INC (1)
CALLISTO PHARMACEUTICALS INC (2)
Canbiola, Inc. (1)
Cannabics Pharmaceuticals Inc. (1)
CANNAPHARMARX, INC. (1)
Cantabio Pharmaceuticals Inc. (1)
CARDAX, INC. (5)
Catalent Inc (3)
Celator Pharmaceuticals Inc (1)
CELGENE CORP (5)
Cerecor Inc. (4)
CHIASMA, INC (1)
China Pharmaceuticals Inc (1)
CinCor Pharma, Inc. (1)
Cingulate Inc. (1)
Citius Pharmaceuticals, Inc. (1)
CLS Holdings USA, Inc. (1)
Cocrystal Pharma, Inc. (6)
COLLAGENEX PHARMACEUTICALS INC (1)
COLLEGIUM PHARMACEUTICAL, INC (2)
CoLucid Pharmaceuticals, Inc. (1)
ContraVir Pharmaceuticals, Inc. (2)
COSMO VENTURES INC (1)
CPEX Pharmaceuticals, Inc. (1)
CUBIST PHARMACEUTICALS INC (4)
Cure Pharmaceutical Holding Corp. (2)
Dova Pharmaceuticals Inc. (1)
DURECT CORP (1)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (2)
Elanco Animal Health Inc (3)
ELITE PHARMACEUTICALS INC (1)
Eloxx Pharmaceuticals, Inc. (2)
ENCYSIVE PHARMACEUTICALS INC (1)
Endo International plc (4)
Endo Pharmaceuticals Solutions Inc. (2)
EPIX Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (1)
Exactus, Inc. (1)
EyePoint Pharmaceuticals, Inc. (1)
EYETECH PHARMACEUTICALS INC (1)
FERMAVIR PHARMACEUTICALS, INC. (1)
Foamix Pharmaceuticals Ltd. (2)
FRONTIER OILFIELD SERVICES INC (3)
Furiex Pharmaceuticals, Inc. (1)
GB SCIENCES INC (1)
GENAISSANCE PHARMACEUTICALS INC (2)
GRAYBUG VISION, INC. (2)
GUILFORD PHARMACEUTICALS INC (1)
HARROW HEALTH, INC. (2)
Horizon Pharma plc (5)
IDENIX PHARMACEUTICALS INC (1)
Ikena Oncology, Inc. (2)
IMAGING3 INC (2)
INNOVATE BIOPHARMACEUTICALS, INC. (4)
Innoviva, Inc. (2)
Innovive Pharmaceuticals, Inc. (1)
INSPIRE PHARMACEUTICALS INC (1)
Intersect ENT, Inc. (1)
Intra-Cellular Therapies, Inc. (2)
ISTA PHARMACEUTICALS INC (2)
Item 9 Labs Corp. (3)
Jaguar Health, Inc. (1)
JAVELIN PHARMACEUTICALS, INC (3)
Jazz Pharmaceuticals plc (5)
Johnson & Johnson (3)
JUNIPER PHARMACEUTICALS INC (1)
Jushi Holdings Inc. (3)
Kala Pharmaceuticals, Inc. (1)
KING PHARMACEUTICALS INC (1)
KOS PHARMACEUTICALS INC (1)
Lev Pharmaceuticals Inc (1)
Level Brands, Inc. (5)
Lexaria Bioscience Corp. (4)
Lipocine Inc. (1)
Liquidia Corp (2)
Mallinckrodt (3)
MAP Pharmaceuticals, Inc. (1)
Marijuana Co of America, Inc. (5)
Medicine Man Technologies, Inc. (10)
MEMORY PHARMACEUTICALS CORP (1)
Menlo Therapeutics Inc. (3)
Merck (1)
MICROCHANNEL TECHNOLOGIES CORP (7)
MJ BIOTECH, INC. (1)
MYnd Analytics, Inc. (2)
MyoKardia Inc (1)
Nabriva Therapeutics plc (1)
NEKTAR THERAPEUTICS (1)
Neos Therapeutics, Inc. (1)
Neuralstem, Inc. (1)
NEW RIVER PHARMACEUTICALS INC (1)
NewBridge Global Ventures, Inc. (3)
Notis Global, Inc. (2)
NOVEN PHARMACEUTICALS INC (2)
NPS PHARMACEUTICALS INC (2)
NURX PHARMACEUTICALS, INC. (1)
Omthera Pharmaceuticals, Inc. (1)
OncoMed Pharmaceuticals Inc (1)
One World Pharma, Inc. (2)
ONYX PHARMACEUTICALS INC (3)
OPIANT PHARMACEUTICALS, INC. (1)
OPTIMER PHARMACEUTICALS INC (1)
ORAMED PHARMACEUTICALS INC. (1)
OSCIENT PHARMACEUTICALS CORP (1)
OSI PHARMACEUTICALS INC (2)
Pacira Pharmaceuticals, Inc. (2)
Paratek Pharmaceuticals, Inc. (1)
PEAK PHARMACEUTICALS, INC. (2)
Perrigo (1)
Pfizer (5)
PHARMOS CORP (4)
Phathom Pharmaceuticals, Inc. (1)
Phibro Animal Health Corporation (1)
Phoenix Life Sciences International Limited. (1)
Pivot Pharmaceuticals Inc. (1)
PLAYERS NETWORK (1)
PLx Pharma Inc. (1)
PONIARD PHARMACEUTICALS, INC. (2)
PRAECIS PHARMACEUTICALS INC (1)
Prestige Brands Holdings Inc (1)
Provention Bio, Inc. (1)
Pulmatrix, Inc. (1)
QUANTA INC (2)
QUESTCOR PHARMACEUTICALS INC (1)
Ra Pharmaceuticals, Inc. (1)
RELMADA THERAPEUTICS, INC. (1)
RespireRx Pharmaceuticals Inc. (2)
resTORbio, Inc. (1)
Roivant Sciences Ltd. (2)
Sagent Pharmaceuticals, Inc. (2)
SALIX PHARMACEUTICALS LTD (4)
Satsuma Pharmaceuticals, Inc. (2)
SCICLONE PHARMACEUTICALS INC (1)
SGX PHARMACEUTICALS, INC. (1)
SIGA TECHNOLOGIES INC (1)
Sirtris Pharmaceuticals, Inc. (1)
Somanta Pharmaceuticals Inc. (2)
Sucampo Pharmaceuticals, Inc. (2)
SUNWIN STEVIA INTERNATIONAL, INC. (1)
Supernus Pharmaceuticals, Inc. (2)
SYNERGY PHARMACEUTICALS, INC. (3)
Synovics Pharmaceuticals (1)
Target Group Inc. (1)
Targeted Medical Pharma, Inc. (2)
TAURIGA SCIENCES, INC. (5)
Tenzing Acquisition Corp. (1)
Terra Tech Corp. (12)
TETRALOGIC PHARMACEUTICALS CORP (1)
TETRAPHASE PHARMACEUTICALS INC (7)
Textmunication Holdings, Inc. (1)
The Medicines Company (4)
TherapeuticsMD, Inc. (4)
Tilray, Inc. (1)
TITAN PHARMACEUTICALS INC (1)
Tribute Pharmaceuticals Canada Inc. (2)
Trubion Pharmaceuticals, Inc (1)
Trulieve Cannabis Corp. (1)
Urigen Pharmaceuticals, Inc. (4)
Urovant Sciences Ltd. (1)
VALEANT PHARMACEUTICALS INTERNATIONAL (3)
Valera Pharmaceuticals Inc (1)
Vallon Pharmaceuticals, Inc. (1)
VIA Pharmaceuticals, Inc. (2)
VICURON PHARMACEUTICALS INC (1)
VioQuest Pharmaceuticals, Inc. (2)
Vitae Pharmaceuticals, Inc (1)
Vitality Biopharma, Inc. (1)
Winston Pharmaceuticals, Inc. (3)
ZOGENIX, INC. (7)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Agreement and Plan of Merger dated as of June 1, 2022, by and between the Registrant and 60 Degrees Pharmaceuticals, LLC (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 28, 2023)
Agreement and Plan of Merger, dated April 24, 2023, by and among Assertio Holdings, Inc., Spade Merger Sub 1, Inc. and Spectrum Pharmaceuticals, Inc. (Form of CVR Agreement... (Assertio Holdings, Inc., Filed With SEC on April 25, 2023)
Tender and Support Agreement, dated as of April 16, 2023, by among Shin Nippon Biomedical Laboratories, Ltd., SNBL23 Merger Sub, Inc. and certain stockholders and directors of the... (Satsuma Pharmaceuticals, Inc., Filed With SEC on April 17, 2023)
Agreement and Plan of Merger, dated as of April 16, 2023, by and among Satsuma Pharmaceuticals, Inc., Shin Nippon Biomedical Laboratories, Ltd. and SNBL23 Merger Sub, Inc (Satsuma Pharmaceuticals, Inc., Filed With SEC on April 17, 2023)
Agreement and Plan of Merger dated as of June 1, 2022, by and between the Registrant and 60 Degrees Pharmaceuticals, LLC (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on April 3, 2023)
Agreement and Plan of Merger, by and among Pfizer Inc., Aris Merger Sub, Inc. and Seagen Inc., dated as of March 12, 2023 (Pfizer, Filed With SEC on March 13, 2023)
Agreement and Plan of Merger, dated as of March 12, 2023, among the Company, Parent and Purchaser (pursuant to Item 601(a)(5) of Regulation S-K, the Company hereby agrees to... (Provention Bio, Inc., Filed With SEC on March 13, 2023)
Form of Support Agreement, dated February 24, 2023, by and among Adamis Pharmaceuticals, Inc., Aardvark Merger Sub, Inc., DMK Pharmaceuticals Corporation, and certain stockholders... (Adamis Pharmaceuticals Corp, Filed With SEC on February 27, 2023)
Agreement and Plan of Merger and Reorganization, dated as of February 24, 2023, by and among Adamis Pharmaceuticals, Inc., Adamis Merger Sub, Inc., and DMK Pharmaceuticals... (Adamis Pharmaceuticals Corp, Filed With SEC on February 27, 2023)
Amendment to Agreement and Plan of Merger, dated as of February 17, 2023, by and among Vallon Pharmaceuticals, Inc., GRI Bio, Inc., and Vallon Merger Sub, Inc (Vallon Pharmaceuticals, Inc., Filed With SEC on February 24, 2023)
First Amendment to the Agreement and Plan of Merger and Reorganization, dated November 21, 2022, by and among CalciMedica, Inc., Camaro Merger Sub, Inc. and Graybug Vision, Inc.,... (GRAYBUG VISION, INC., Filed With SEC on February 16, 2023)
Agreement and Plan of Merger dated as of June 1, 2022, by and between the Registrant and 60 Degrees Pharmaceuticals, LLC (60 DEGREES PHARMACEUTICALS, INC., Filed With SEC on January 31, 2023)
Agreement and Plan of Merger and Reorganization, dated January 17, 2023, by and among Angion Biomedica Corp., Arkham Merger Sub, Inc. and Elicio Therapeutics, Inc (Angion Biomedica Corp., Filed With SEC on January 17, 2023)
Agreement and Plan of Merger, dated as of January 8, 2023, by and among CinCor Pharma, Inc., AstraZeneca Finance and Holdings Inc. and Cinnamon Acquisition, Inc (CinCor Pharma, Inc., Filed With SEC on January 9, 2023)
Agreement and Plan of Merger between Body and Mind Inc., DEP Nevada, Inc., BaM Body and Mind Dispensary NJ, Inc., CraftedPlants NJ Corp. and the shareholders of CraftedPlants NJ... (BODY & MIND INC., Filed With SEC on December 23, 2022)
Agreement and Plan of Merger and Reorganization, dated November 21, 2022, by and among the CalciMedica, Inc., Camaro Merger Sub, Inc. and Graybug Vision, Inc (GRAYBUG VISION, INC., Filed With SEC on November 22, 2022)
Agreement and Plan of Merger, dated as of October 31, 2022, by and among Johnson & Johnson, Athos Merger Sub, Inc. and ABIOMED, Inc (Johnson & Johnson, Filed With SEC on November 1, 2022)
Agreement and Plan of Merger, dated as of August 22, 2022, by and among the Company, Parent and Merger Sub (AERIE PHARMACEUTICALS INC, Filed With SEC on August 23, 2022)
Merger and Membership Interest Purchase Agreement, dated April 16, 2021, by and among Jushi MA, Inc., Jushi Inc, Jushi Holdings Inc., Sammartino Investments LLC, Natures Remedy of... (Jushi Holdings Inc., Filed With SEC on July 22, 2022)
First Amendment to Merger and Membership Interest Purchase Agreement, dated May 13, 2021, by and between Sammartino Investments LLC Jushi Inc (Jushi Holdings Inc., Filed With SEC on July 22, 2022)
Second Amendment to Merger and Membership Interest Purchase Agreement, dated September 7, 2021, by and between Sammartino Investments LLC Jushi Inc (Jushi Holdings Inc., Filed With SEC on July 22, 2022)
Agreement and Plan of Merger, dated as of July 10, 2022, by and among Innoviva, Inc., Innoviva Acquisition Sub, Inc., and La Jolla Pharmaceutical Company (Innoviva, Inc., Filed With SEC on July 11, 2022)
Form of Warrant assumed as part of the Nanomix Merger (Boston Therapeutics, Inc., Filed With SEC on July 6, 2022)
Business Combination Agreement, dated as of May 1, 2021, by and among Montes Archimedes Acquisition Corp., Roivant Sciences Ltd. and Rhine Merger Sub, Inc (Roivant Sciences Ltd., Filed With SEC on June 28, 2022)
Amendment No. 1 to the Business Combination Agreement, dated June 9, 2021, by and among Montes Archimedes Acquisition Corp., Roivant Sciences Ltd. and Rhine Merger Sub, Inc (Roivant Sciences Ltd., Filed With SEC on June 28, 2022)
Agreement and Plan of Merger, dated as of May 27, 2022, among TherapeuticsMD, Inc., Athene Parent, Inc. and Athene Merger Sub, Inc (TherapeuticsMD, Inc., Filed With SEC on May 31, 2022)
Agreement and Plan of Merger, dated as of May 23, 2022, by and among Innoviva, Inc., Innoviva Merger Sub, Inc., and Entasis Therapeutics Holdings Inc (Innoviva, Inc., Filed With SEC on May 24, 2022)
Agreement and Plan of Merger between Bright Green Corporation and Naseeb Inc. dated as of November 10, 2020 (Bright Green Corp, Filed With SEC on May 5, 2022)
Agreement and Plan of Merger between Bright Green Corporation and Grants Greenhouse Growers Inc. dated as of October 30, 2020 (Bright Green Corp, Filed With SEC on May 5, 2022)
Agreement and Plan of Merger between Bright Green Corporation and Bright Green Grown Innovation LLC dated May 28, 2019 (Bright Green Corp, Filed With SEC on May 5, 2022)
Form of Merger Note (4Front Ventures Corp., Filed With SEC on April 22, 2022)
Amendment to Agreement and Plan of Merger by and among 4Front Ventures Corp., Island Merger Sub, Inc., Island Global Holdings, Inc., and Navy Capital SR LLC, dated April 8, 2022 (4Front Ventures Corp., Filed With SEC on April 22, 2022)
Agreement and Plan of Merger, dated as of March 30, by and among 4Front Ventures Corp., Island Merger Sub, Inc., Island Global Holdings, Inc., and Navy Capital SR LLC. Press... (4Front Ventures Corp., Filed With SEC on April 6, 2022)
Joint Venture Agreement (MICROCHANNEL TECHNOLOGIES CORP, Filed With SEC on March 16, 2022)
Amendment No. 1 to Agreement and Plan of Merger, dated February 9, 2022, by and among Medicine Man Technologies, Inc., Emerald Fields Merger Sub, LLC, MCG, LLC, the Members of... (Medicine Man Technologies, Inc., Filed With SEC on February 15, 2022)
Contract to Buy and Sell Real Estate (Commercial), dated January 26, 2022, by and between Emerald Fields Merger Sub, LLC and Manitou Springs Real Estate Development, LLC (Medicine Man Technologies, Inc., Filed With SEC on February 15, 2022)
Agreement and Plan of Merger, dated as of February 14, 2022, by and among Collegium Pharmaceutical, Inc., Bristol Acquisition Company Inc. and BioDelivery Sciences International,... (BIODELIVERY SCIENCES INTERNATIONAL INC, Filed With SEC on February 15, 2022)
Amendment to Rider to Contract to Buy and Sell Real Estate by and between Emerald Fields Merger Sub, LLC and Manitou Springs Real Estate Development, LLC (Medicine Man Technologies, Inc., Filed With SEC on February 15, 2022)
Rider to Contract to Buy and Sell Real Estate by and between Emerald Fields Merger Sub, LLC and Manitou Springs Real Estate Development, LLC (Medicine Man Technologies, Inc., Filed With SEC on February 15, 2022)
Bill of Sale and Assignment and Assumption Agreement, dated February 9, 2022, by and between Emerald Fields Merger Sub, LLC and 1508 Management, LLC (Medicine Man Technologies, Inc., Filed With SEC on February 15, 2022)